Current Chemical Genomics and Translational Medicine
2008, 1 : 27-33Published online 2008 February 25. DOI: 10.2174/1875397300801010027
Publisher ID: CCGTM-1-27
RESEARCH ARTICLE
Cellular Assays for High-Throughput Screening for Modulators of Trk Receptor Tyrosine Kinases
* Address correspondence to this author at the Invitrogen Corporation, Discovery Sciences, 501 Charmany Drive, Madison, WI 53719, USA; E-mail: Kun.Bi@invitrogen.com
ABSTRACT
Trk receptor tyrosine kinases are required for signal transduction initiated by neurotrophins leading to cell proliferation, differentiation, survival and death. Alterations in Trk kinase activity have been linked to various diseases. To address the need for cell-based assays for screening and studying the selectivity of Trk kinase modulators, we developed high-throughput cell-based assays for Trk receptor kinases using nuclear factor of activated T-cells (NFAT) beta-lactamase reporter lines stably expressing full length human Trk kinases. These assays were functionally validated with cognate neurotrophin(s), inhibitors and TRK RNAi oligos and demonstrated for their utility in identifying potent and selective modulators of Trk receptor kinases.